Track the Algernon Pharmaceuticals Inc. share price and the full management transaction log of the company, a publicly traded company based in Canada. Shares trade on the CA market, under the authority of SEDI. The latest transaction was filed on 2 August 2024 (16 - Acquisition or disposition under a prospectus exemption). Among the most active insiders: Moreau, Christopher. All data is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
Algernon Pharmaceuticals Inc. 是一家生物制药公司,专注于开发严重疾病的新疗法。该公司在多伦多证券交易所上市,股票代码为 XTSE。